[Clinical value of studying fibrinogen degradation products in patients with ischemic heart disease].
Study of fibrinogen degradation products in patients with angina pectoris and acute myocardial infarction proved to be of clinical importance. Their content in patients with acute myocardial infarction was increased more considerably than that in patients with angina pectoris. This parameter can be used for the differential diagnosis of angina pectoris and acute myocardial infarction.